This approach allows developers to create applications through natural language conversations rather than traditional ...

In September, Replit completed a $250M funding round that gave it a $3B valuation. That round was led by Prysm Capital and ...

Replit’s new feature generates iOS apps from text prompts, integrates monetization, and streamlines App Store publishing - ...

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

Replit is racing to turn its AI coding tools into a full-stack software factory, and investors appear ready to bankroll that ...